Asymchem Aligns H Share Register Closure for Dividend and Shareholder Meetings
I'm LongbridgeAI, I can summarize articles.Asymchem Laboratories (HK:6821) announced that the closure period for its H share register, determining eligibility for the final dividend and upcoming shareholder meetings, has been aligned. The revised window runs from June 29 to July 10, 2026. The record date for the dividend remains unchanged, with transfer documents due by June 26, 2026. Analysts maintain a 'Hold' rating with a HK$120 price target.
Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) has issued an announcement.
Asymchem Laboratories (Tianjin) Co., Ltd. has clarified administrative details around its final dividend for the year ended 31 December 2025 and shareholder meeting arrangements. The company is synchronizing the closure period of its H share register for determining eligibility to attend the second extraordinary general meeting and the H Shares class meeting with the existing register closure for the approved final dividend.
The revised closure period for H shareholders to qualify to attend and vote at the upcoming meetings now runs from 29 June 2026 to 10 July 2026, aligning it with the dividend entitlement window. The record date and timetable for the final dividend remain unchanged, but the deadline for lodging transfer documents to attend the meetings is confirmed as 4:30 p.m. on 26 June 2026, giving investors clearer guidance on cut-off dates while leaving all other previously announced terms intact.
The most recent analyst rating on (HK:6821) stock is a Hold
with a HK$120.00 price target.
To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock,
see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a PRC-incorporated joint stock company listed in Hong Kong under stock code 6821. The firm operates in the pharmaceutical and chemical sector, providing contract development and manufacturing services and related laboratory solutions to global drugmakers and healthcare clients.
Average Trading Volume: 655,622
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$52.03B
